Status:
COMPLETED
Intervention for Young Adults With Multiple Sclerosis
Lead Sponsor:
Azienda Ospedaliera Universitaria Integrata Verona
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
This study aims to develop - in collaboration with patients with multiple sclerosis (MS)- a psychosocial and physical activity intervention (i.e., ESPRIMO intervention) for young adults with MS target...
Detailed Description
Being the most common neurological disease causing disability in young adults, multiple sclerosis (MS) does not only impair physical functions but is also often associated with fatigue, symptoms of de...
Eligibility Criteria
Inclusion
- As different samples of patients and healthcare professionals will be enrolled in the different phases of the studies, inclusion and exclusion criteria vary:
- Explorative pre-phase "Exploring the psychological impact of the COVID-19 emergency"
- age range: 18-45 years;
- MS Diagnosis;
- Italian speakers;
- electronic informed consent signed.
Exclusion
- N/A
- Co-creation phase - Survey with young adults with MS
- Inclusion Criteria:
- age range: 18-45 years;
- MS diagnosis;
- Italian speakers;
- electronic informed consent signed.
Key Trial Info
Start Date :
May 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2022
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT04431323
Start Date
May 13 2020
End Date
October 30 2022
Last Update
February 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria Integrata Verona, Policlinico G.B. Rossi
Verona, Veneto, Italy, 37134